Application of fish technique for cytogenetic analysis in chronic myeloid leukemia patients

Experimental Oncology

Volumn 25, Issue 1, 2003, Pages 74-76

  Kasakyan, S ^a   Tachdjian, G ^b   Movsessyan, E ^c   Dagbhashyan, S ^c   Muradyan, L ^c   Aboura, A ^b   Hovannisyan, A ^c   Muradyan, A ^a   Mkrtchyan, H ^a   Arutyunyan, R ^a  

^a YEREVAN STATE UNIVERSITY   (Armenia)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c Armenian Ministry of Health   (Armenia)

Author keywords

Chronic myeloid leukemia; Cytogenetics; FISH; Philadelphia chromosome

Indexed keywords

ADULT; ARMENIA; ARTICLE; CANCER DIAGNOSIS; CHROMOSOME 22; CHROMOSOME 9; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTERMETHOD COMPARISON; KARYOTYPE; MALE; PHILADELPHIA 1 CHROMOSOME; PROGNOSIS; CHROMOSOME ANALYSIS; CHRONIC LEUKEMIA; CONTROLLED STUDY; GENE TRANSLOCATION; HUMAN CELL; HUMAN TISSUE; INTERPHASE; METAPHASE; MYELOID LEUKEMIA; USSR;

EID: 0037695020     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Nowell PC, Hungerford DA. A minute chromosome in human granulocytic leukemia. Science 1960; 132: 1497.
2. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290-3.
3. Heim S, Mitelman F. Cancer cytogenetics. Chromosomal and molecular abberations of tumor cells. Willeylis: 2nd edition; 1995: 248 p.
4. Fugazza G, Bruzzone R, Dejana AM, Gobbi M, Ghio R, Patrone F, Rattenni S, Sessarego M. Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridization. Leukemia 1995; 9: 109-4.
5. Martinet D, Muhlematter D, Jotterand BM. Fluorescent in situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukaemia. Schweiz Med Wochenschr 1996; 18: 855-63.
6. Mohr B, Bornhauser M, Platzbecker U, FreibergRichter J, Naumann R, Prange-Krex G, Mohm J, Kroschinsky F, Ehninger G, Thiede C. Problems with interphase fluorescence in situ hybridization in detecting BCRABL-positive cells in some patients using a novel technique with extra signals. Cancer Genet Cytogenet 2001; 127: 111-7.
7. Cuneo A, Bigoni R, Emmanuel B, Smit E, Rigolin GM, Roberti MG, Bardi A, Piva N, Scapoli G, Castoldi G, Van Den Berghe H, Hagemeijer A. Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding analysis. Leukemia 1998; 12: 1718-23.
8. Yanagi M, Shinjo K, Takeshita A, Tobita T, Yano K, Kobayashi M, Terasaki H, Naoe T, Ohnishi K, Ohno R. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells. Leukemia 1999; 13: 542-52.
9. Le Gouill S, Talmant P, Milpied N, Daviet A, Ancelot M, Moreau P, Harousseau JL, Bataille R, Avet-Loiseau H. Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia. J Clin Oncol 2000; 18: 1533-8.
10. Mauritzson N, Johansson B, Albin M, Billstrom R, Ahlgren T, Mikoczy Z, Nilsson PG, Hagmar L, Mitelman F. A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. Eur J Haematol 1999; 62: 95-102.
11. Oguma S, Takatsuki K, Uchino H, Kamada N, Oguma N, Kuramoto A. Factors influencing survival in Philadelphia chromosome positive chronic myelocytic leukemia. Cancer 1982; 15: 2928-34.
12. Huntly BJ, Reid AG, Bench AJ, Campbell LJ, Telford N, Shepherd P, Szer J, Prince HM, Turner P, Grace C, Nacheva EP, Green AR. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 2001; 15: 1732-8.